Suzuki Toru, Nagai Ryozo
Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Aug;855(1):28-34. doi: 10.1016/j.jchromb.2007.02.043. Epub 2007 Mar 4.
Here, we report on our proteomic studies in the field of cardiovascular medicine. Our research has been focused on understanding the role of proteins in cardiovascular disease with a particular focus on epigenetic regulation and biomarker discovery, with the objective of better understanding cardiovascular pathophysiology to lead to the development of new and better diagnostic and therapeutic methods. We have used mass spectrometry for over 5 years as a viable method to investigate protein-protein interactions and post-translational modifications in cellular proteins as well as a method to investigate the role of extra-cellular proteins. Use of mass spectrometry not only as a research tool but also as a potential diagnostic tool is a topic of interest. In addition to these functional proteomics studies, structural proteomic studies are also done with expectations to allow for pinpoint drug design and therapeutic intervention. Collectively, our proteomics studies are focused on understanding the functional role and potential therapeutically exploitable property of proteins in cardiovascular disease from both intra-cellular and extra-cellular aspects with both functional as well as structural proteomics approaches to allow for comprehensive analysis.
在此,我们报告我们在心血管医学领域的蛋白质组学研究。我们的研究重点是了解蛋白质在心血管疾病中的作用,特别关注表观遗传调控和生物标志物发现,目的是更好地理解心血管病理生理学,以推动新的、更好的诊断和治疗方法的开发。我们使用质谱技术超过5年,作为研究细胞内蛋白质的蛋白质-蛋白质相互作用和翻译后修饰的可行方法,以及研究细胞外蛋白质作用的方法。将质谱技术不仅用作研究工具,还用作潜在的诊断工具是一个令人感兴趣的话题。除了这些功能蛋白质组学研究外,还进行了结构蛋白质组学研究,期望能实现精准药物设计和治疗干预。总体而言,我们的蛋白质组学研究专注于从细胞内和细胞外两个方面,运用功能蛋白质组学和结构蛋白质组学方法,全面分析蛋白质在心血管疾病中的功能作用和潜在的可用于治疗的特性。